Biosynthesis of Cannabinoids - Podcast Interview with Jeremy Friedberg, CSO of LAVVAN by Global Engage Podcasts

Recently we conducted a podcast interview with Jeremy Friedberg, CSO of LAVVAN and speaker during the upcoming iCBD3: International Cannabinoid Drug Discovery and Development Congress, March 4-5, in Rotterdam, Netherlands.

Discussion questions included:

[0:48] Can you discuss some of the major advantages biosynthesis of cannabinoids has over traditional cultivation?

[2:42] Can you share your thoughts on the major challenges currently associated with biosynthesis of cannabinoids?

[4:50] What are some of the more exciting types of cannabinoids being discovered beyond CBD and THC?

[6:20] What about the terpene side of things?

[7:34] What is your outlook for the future of synthesized cannabinoids? Will this completely replace traditional means?

To learn more about Jeremy's work, and to view the iCBD3 program agenda, please visit: www.global-engage.com/event/cannabinoid-drug-discovery